Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iodixanol vs iopromide for risk of contrast-induced nephropathy in low-risk cancer patients
2010-019740-39Phase 3Active
- Sponsor
- Istituti Fisioterapici Ospitalieri
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in contrast-induced nephropathy (CIN) comparing Iodixanol arm with Iopromide arm (2 arms). Primary endpoint: Incidence of contrast-induced nephropathy. Started Apr 2010; status: active.
02
Drugs
iodixanoliopromide
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on 2010-019740-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019740-39.